Labcorp Holdings Inc. (LH)
Automate Your Wheel Strategy on LH
With Tiblio's Option Bot, you can configure your own wheel strategy including LH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LH
- Rev/Share 169.1115
- Book/Share 104.6873
- PB 2.7306
- Debt/Equity 0.8363
- CurrentRatio 1.4239
- ROIC 0.073
- MktCap 23651370000.0
- FreeCF/Share 14.6182
- PFCF 19.6114
- PE 26.8537
- Debt/Assets 0.3919
- DivYield 0.0101
- ROE 0.1028
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | LH | HSBC Securities | Buy | Hold | -- | $260 | July 10, 2025 |
| Initiation | LH | Redburn Atlantic | -- | Buy | -- | $276 | April 2, 2025 |
| Upgrade | LH | Citigroup | Neutral | Buy | $250 | $300 | March 4, 2025 |
| Upgrade | LH | Evercore ISI | In-line | Outperform | $260 | $265 | Jan. 7, 2025 |
| Resumed | LH | Jefferies | -- | Buy | $265 | $275 | Dec. 10, 2024 |
| Initiation | LH | Piper Sandler | -- | Neutral | -- | $235 | Oct. 1, 2024 |
News
Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide
Published: February 23, 2026 by: PRNewsWire
Sentiment: Neutral
AISight® Dx will support fully digital workflows and AI-enabled insights across Labcorp's network of anatomic pathology labs and hospital collaborations to improve efficiency, collaboration and patient care BURLINGTON, N.C., Feb. 23, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with PathAI to deploy AISight® Dx1, an FDA-cleared digital pathology platform, across its national network of anatomic pathology labs and hospital collaborations.
Read More
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term
Published: February 19, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
Published: February 18, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market
Published: February 17, 2026 by: Zacks Investment Research
Sentiment: Negative
LH beats Q4 EPS estimates with 18% growth, but a revenue miss and cautious investor reaction push shares lower in pre-market trading.
Read More
Labcorp (LH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: February 17, 2026 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Labcorp (LH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?
Published: February 11, 2026 by: Zacks Investment Research
Sentiment: Positive
Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Stay Ahead of the Game With Labcorp (LH) Q4 Earnings: Wall Street's Insights on Key Metrics
Published: February 11, 2026 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Labcorp (LH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Read More
Labcorp's Q4 Earnings Preview: What's in Store for the Stock?
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
LH heads into its Q4 earnings report with rising revenue and EPS expectations, driven by Diagnostics momentum, acquisitions and expanding test demand.
Read More
Should Labcorp Stock Stay in Your Portfolio Right Now?
Published: January 06, 2026 by: Zacks Investment Research
Sentiment: Negative
LH's growth bets in specialty testing and acquisitions support its outlook, but macro pressures and currency headwinds remain key risks.
Read More
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
Published: December 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now?
Published: December 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp's strategic partnerships, specialty test growth and more attractive valuation tilt the balance as it emerges stronger than Hologic right now.
Read More
Is the Options Market Predicting a Spike in Labcorp Holdings Stock?
Published: December 15, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors need to pay close attention to LH stock based on the movements in the options market lately.
Read More
Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks
Published: December 15, 2025 by: Business Wire
Sentiment: Neutral
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures. The financing is intended to accelerate Cofactor's nationwide expansion and broaden patient access to its immunotherapy-response diagnostics. Ascension Ventures, the strategic investment arm of 13 leading U.S. health systems across 22 states, representing more than $100.
Read More
Labcorp (LH) Up 8.1% Since Last Earnings Report: Can It Continue?
Published: November 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp (LH) reported earnings 30 days ago. What's next for the stock?
Read More
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
Published: November 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
LH Shares Gain Following Publication of New Plasma Detect MRD Data
Published: November 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp shares edge higher as new studies spotlight Plasma Detect's role in tracking MRD and improving post-surgery cancer detection.
Read More
Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Neutral
Labcorp Holdings Inc. (NYSE:LH ) Q3 2025 Earnings Call October 28, 2025 9:00 AM EDT Company Participants Christin O'Donnell - Vice President of Investor Relations Adam Schechter - President, CEO & Chairman Julia Wang - CFO & Executive VP Conference Call Participants Lisa Gill - JPMorgan Chase & Co, Research Division Michael Cherny - Leerink Partners LLC, Research Division Jack Meehan - Nephron Research LLC Patrick Donnelly - Citigroup Inc., Research Division Erin Wilson Wright - Morgan Stanley, Research Division Andrew Brackmann - William Blair & Company L.L.C., Research Division Joanna Dynak Kevin Caliendo - UBS Investment Bank, Research Division …
Read More
LH Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Neutral
Labcorp's Q3 earnings beat forecasts and margins improve, but a trimmed 2025 sales outlook sends shares down.
Read More
Here's Why Labcorp Holdings (LH) is a Strong Growth Stock
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Labcorp (LH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Labcorp (LH) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
LH vs. DHR: Which Stock Is the Better Value Option?
Published: October 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical Services sector have probably already heard of Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Praia Health, Providence, and Labcorp Collaborate to Transform Patient Engagement and Lab Order Adherence
Published: October 20, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--A streamlined digital experience improved lab order adherence, reduced no-shows, and enhanced operational efficiency at Providence.
Read More
Labcorp Gears Up to Report Q3 Earnings: What's in Store for the Stock?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
LH is poised for Q3 growth, with revenue and EPS estimates pointing higher as diagnostics and biopharma units deliver strong performances.
Read More
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term
Published: October 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
3 Medical Service Industry Stocks Poised to Counter Workforce Issues
Published: October 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Here are three resilient medical services stocks, Labcorp, Charles River Laboratories and Teladoc, that are poised to outperform amid staffing shortages and digital healthcare growth.
Read More
Labcorp (LH) Upgraded to Buy: What Does It Mean for the Stock?
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities
Published: September 30, 2025 by: PRNewsWire
Sentiment: Neutral
Labcorp to leverage Roche's digital pathology technology to expand access, enhance efficiency and support AI integration across anatomic pathology services BURLINGTON, N.C. , Sept. 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today a collaboration with Roche to implement the company's FDA-cleared VENTANA® DP 600 and DP 200 slide scanners.
Read More
Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Reasons to Add Labcorp Stock to Your Portfolio Right Now
Published: September 23, 2025 by: Zacks Investment Research
Sentiment: Positive
LH's biopharma lab growth and efficiency gains boost momentum, but currency and macro pressures weigh on its outlook.
Read More
About Labcorp Holdings Inc. (LH)
- IPO Date 1990-03-29
- Website https://www.labcorp.com
- Industry Medical - Equipment & Services
- CEO Adam H. Schechter
- Employees 60900